Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator

被引:16
作者
Leiva-Salinas, Carlos [1 ]
Patrie, James T. [2 ]
Xin, Wenjun [2 ]
Michel, Patrik [3 ]
Jovin, Tudor [4 ]
Wintermark, Max [5 ]
机构
[1] Univ Virginia, Dept Radiol, Charlottesville, VA USA
[2] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[3] CHU Vaudois, Dept Neurol, CH-1011 Lausanne, Switzerland
[4] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[5] Stanford Univ, Dept Radiol, Neuroradiol Div, Stanford, CA 94305 USA
基金
瑞士国家科学基金会;
关键词
brain infarction; perfusion; stroke; tissue plasminogen activator; tomography; x-ray computed; ACUTE ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; IMAGING SELECTION; RANDOMIZED-TRIAL; THROMBOLYSIS; THERAPY; DESMOTEPLASE; DIFFUSION; PENUMBRA; VOLUME;
D O I
10.1161/STROKEAHA.115.011066
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Our objective is to determine the performance of the combination of likelihood of arterial recanalization and tissue fate to predict functional clinical outcome in patients with acute stroke. Methods-Clinical, imaging, and outcome data were collected in 173 patients with acute ischemic stroke who presented within 4.5 hours from symptom onset, in the time window eligible for intravenous tissue-type plasminogen activator. Imaging data included Alberta Score Program Early Computed Tomographic Score (ASPECTS), site of occlusion, volume of ischemic core and penumbra, and recanalization. Outcome data consisted of modified Rankin Scale score at 90 days. We classified patients based on their baseline imaging characteristics and treatment with intravenous tissue-type plasminogen activator (yes/no) according to 5 different hypothetical prognostic algorithms: (1) based on whether patients received intravenous tissue-type plasminogen activator, (2) based on ASPECTS, (3) based on the site of occlusion, (4) based on volume of ischemic core and penumbra, and (5) based on a matrix of predicted recanalization and volume of ischemic core and penumbra. We compared the performance of such algorithms to predict good clinical outcome, defined as modified Rankin Scale score of <= 2 at 90 days. Results-One hundred and twenty-four patients received intravenous tissue-type plasminogen activator; 49 did not. In the group that was treated, 46 (37%) had good outcome as opposed to 38.7% in the nontreated. The algorithm that combined the prediction of recanalization with the volume of ischemic core and penumbra showed the highest accuracy to predict good outcome (77.7%) as opposed to others (range, 43.9%-57.2%) Conclusions-The combination of predicted recanalization and tissue fate proved superior to prognosticate good clinical outcome when compared with other usual predictors.
引用
收藏
页码:397 / 403
页数:7
相关论文
共 18 条
[1]   Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].
Albers, Gregory W. ;
Thijs, Vincent N. ;
Wechsle, Lawrence ;
Kemp, Stephanie ;
Schlaug, Gottfried ;
Skalabrin, Elaine ;
Bammer, Roland ;
Kakuda, Wataru ;
Lansberg, Maarten G. ;
Shuaib, Ashfaq ;
Coplin, William ;
Hamilton, Scott ;
Moseley, Michael ;
Marks, Michael P. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517
[2]   A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke [J].
Berkhemer, O. A. ;
Fransen, P. S. S. ;
Beumer, D. ;
van den Berg, L. A. ;
Lingsma, H. F. ;
Yoo, A. J. ;
Schonewille, W. J. ;
Vos, J. A. ;
Nederkoorn, P. J. ;
Wermer, M. J. H. ;
van Walderveen, M. A. A. ;
Staals, J. ;
Hofmeijer, J. ;
van Oostayen, J. A. ;
Nijeholt, G. J. Lycklama A. ;
Boiten, J. ;
Brouwer, P. A. ;
Emmer, B. J. ;
de Bruijn, S. F. ;
van Dijk, L. C. ;
Kappelle, L. J. ;
Lo, R. H. ;
Van Dijk, E. J. ;
de Vries, J. ;
de Kort, P. L. M. ;
van Rooij, W. J. J. ;
van den Berg, J. S. P. ;
van Hasselt, B. A. A. M. ;
Aerden, L. A. M. ;
Dallinga, R. J. ;
Visser, M. C. ;
Bot, J. C. J. ;
Vroomen, P. C. ;
Eshghi, O. ;
Schreuder, T. H. C. M. L. ;
Heijboer, R. J. J. ;
Keizer, K. ;
Tielbeek, A. V. ;
den Hertog, H. M. ;
Gerrits, D. G. ;
van den Berg-Vos, R. M. ;
Karas, G. B. ;
Steyerberg, E. W. ;
Flach, H. Z. ;
Marquering, H. A. ;
Sprengers, M. E. S. ;
Jenniskens, S. F. M. ;
Beenen, L. F. M. ;
van den Berg, R. ;
Koudstaal, P. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (01) :11-20
[3]   Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection [J].
Campbell, B. C. V. ;
Mitchell, P. J. ;
Kleinig, T. J. ;
Dewey, H. M. ;
Churilov, L. ;
Yassi, N. ;
Yan, B. ;
Dowling, R. J. ;
Parsons, M. W. ;
Oxley, T. J. ;
Wu, T. Y. ;
Brooks, M. ;
Simpson, M. A. ;
Miteff, F. ;
Levi, C. R. ;
Krause, M. ;
Harrington, T. J. ;
Faulder, K. C. ;
Steinfort, B. S. ;
Priglinger, M. ;
Ang, T. ;
Scroop, R. ;
Barber, P. A. ;
McGuinness, B. ;
Wijeratne, T. ;
Phan, T. G. ;
Chong, W. ;
Chandra, R. V. ;
Bladin, C. F. ;
Badve, M. ;
Rice, H. ;
de Villiers, L. ;
Ma, H. ;
Desmond, P. M. ;
Donnan, G. A. ;
Davis, S. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) :1009-1018
[4]   Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial [J].
Davis, Stephen M. ;
Donnan, Geoffrey A. ;
Parsons, Mark W. ;
Levi, Christopher ;
Butcher, Kenneth S. ;
Peeters, Andre ;
Barber, P. Alan ;
Bladin, Christopher ;
De Silva, Deidre A. ;
Byrnes, Graham ;
Chalk, Jonathan B. ;
Fink, John N. ;
Kimber, Thomas E. ;
Schultz, David ;
Hand, Peter J. ;
Frayne, Judith ;
Hankey, Graeme ;
Muir, Keith ;
Gerraty, Richard ;
Tress, Brian M. ;
Desmond, Patricia M. .
LANCET NEUROLOGY, 2008, 7 (04) :299-309
[5]   Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset [J].
Furlan, AJ ;
Eyding, D ;
Albers, GW ;
Al-Rawi, Y ;
Lees, KR ;
Rowley, HA ;
Sachara, C ;
Soehngen, M ;
Warach, S ;
Hacke, W .
STROKE, 2006, 37 (05) :1227-1231
[6]   Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke [J].
Goyal, M. ;
Demchuk, A. M. ;
Menon, B. K. ;
Eesa, M. ;
Rempel, J. L. ;
Thornton, J. ;
Roy, D. ;
Jovin, T. G. ;
Willinsky, R. A. ;
Sapkota, B. L. ;
Dowlatshahi, D. ;
Frei, D. F. ;
Kamal, N. R. ;
Montanera, W. J. ;
Poppe, A. Y. ;
Ryckborst, K. J. ;
Silver, F. L. ;
Shuaib, A. ;
Tampieri, D. ;
Williams, D. ;
Bang, O. Y. ;
Baxter, B. W. ;
Burns, P. A. ;
Choe, H. ;
Heo, J. -H. ;
Holmstedt, C. A. ;
Jankowitz, B. ;
Kelly, M. ;
Linares, G. ;
Mandzia, J. L. ;
Shankar, J. ;
Sohn, S. -I. ;
Swartz, R. H. ;
Barber, P. A. ;
Coutts, S. B. ;
Smith, E. E. ;
Morrish, W. F. ;
Weill, A. ;
Subramaniam, S. ;
Mitha, A. P. ;
Wong, J. H. ;
Lowerison, M. W. ;
Sajobi, T. T. ;
Hill, M. D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (11) :1019-1030
[7]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[8]   A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke [J].
Kidwell, Chelsea S. ;
Jahan, Reza ;
Gornbein, Jeffrey ;
Alger, Jeffry R. ;
Nenov, Val ;
Ajani, Zahra ;
Feng, Lei ;
Meyer, Brett C. ;
Olson, Scott ;
Schwamm, Lee H. ;
Yoo, Albert J. ;
Marshall, Randolph S. ;
Meyers, Philip M. ;
Yavagal, Dileep R. ;
Wintermark, Max ;
Guzy, Judy ;
Starkman, Sidney ;
Saver, Jeffrey L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :914-923
[9]   Pretreatment Diffusion-Weighted Imaging Lesion Volume Predicts Favorable Outcome After Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke [J].
Kruetzelmann, Anna ;
Koehrmann, Martin ;
Sobesky, Jan ;
Cheng, Bastian ;
Rosenkranz, Michael ;
Roether, Joachim ;
Schellinger, Peter D. ;
Ringleb, Peter ;
Gerloff, Christian ;
Fiehler, Jens ;
Thomalla, Goetz .
STROKE, 2011, 42 (05) :1251-1254
[10]   Stroke Imaging Research Road Map [J].
Leiva-Salinas, Carlos ;
Hom, Jason ;
Warach, Steven ;
Wintermark, Max .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2011, 21 (02) :239-+